2026 online price guide. Compounded vs brand-name cost paths. HSA/FSA and patient assistance options.
Cash-pay pathsHSA/FSA eligible10 providersReviewed June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Semaglutide without insurance has three main cost paths: brand-name Wegovy cash retail (~$1,300/mo), brand-name through NovoCare patient assistance (income-dependent), or compounded semaglutide through licensed telehealth ($99-$297/mo advertised, $145-$297/mo realistic). The lowest transparent flat-rate compounded option in our 2026 review is NexLife at $145/mo ($1,740/year) — roughly 11% of brand-name cash retail.
Compounded semaglutide — realistic monthly cost
Bar lengths reflect maintenance-dose monthly cost. NexLife at $145/mo flat-rate vs realistic competitor pricing.
True 12-month total reflects maintenance-dose monthly × 12. Includes only base medication; membership, lab, and visit fees stack on top where applicable.
Source: GLP-1 Price Guide pricing review, June 2026.
Semaglutide Cost Without Insurance: All Paths
Path
Monthly cost
Annual cost
FDA-approved?
Wegovy cash retail (no programs)
~$1,300/mo
~$15,600
Yes
Wegovy through NovoCare (income-qualifying)
Variable
Variable
Yes
Ozempic with savings card
Variable
Variable
Yes (T2D label; off-label for weight)
Compounded — NexLife flat-rate
$145/mo
$1,740
No
Compounded — Found
$99-$199+/mo
$1,188-$2,388+
No
Compounded — Henry Meds
~$297/mo
~$3,564
No
Compounded — Hims (dose-tiered)
$199-$399/mo
$2,388-$4,788
No
Pricing reviewed: June 1, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.
Compounded Semaglutide for Cash Patients
For patients without insurance coverage for brand-name semaglutide, compounded semaglutide through licensed telehealth is often the most accessible path. Key considerations:
Not FDA-approved as finished drug product
Prescribed by licensed clinician after patient-specific evaluation
Dispensed by licensed 503A or 503B compounding pharmacy
Quality and pricing varies by provider
HSA/FSA eligible if prescribed for qualifying medical condition
If you'd prefer brand-name Wegovy or Ozempic, patient assistance programs may help:
NovoCare (Novo Nordisk) — Wegovy patient assistance for income-qualifying uninsured patients. Eligibility depends on income, household size, residency status. Visit novocare.com for current criteria.
340B clinics / FQHCs — Federally Qualified Health Centers and 340B-eligible providers can sometimes offer reduced-cost brand-name medications for qualifying patients.
Manufacturer savings cards — Ozempic and Wegovy may have manufacturer savings cards that reduce out-of-pocket for commercially-insured patients (not applicable to cash-pay).
HSA and FSA Eligibility
Compounded semaglutide prescribed for a qualifying medical condition (obesity with BMI ≥30, weight-related comorbidities, type 2 diabetes) can typically be paid with HSA or FSA funds. Documentation requirements:
Prescription from licensed clinician
Receipt showing medical purpose
Letter of medical necessity (sometimes required by HSA administrator)
Frequently asked questions
How much does semaglutide cost without insurance?
Without insurance, semaglutide cost depends on whether you choose brand-name or compounded. Brand-name Wegovy cash retail: approximately $1,300/mo ($15,600/year). Brand-name Wegovy through NovoCare patient assistance: variable. Compounded semaglutide through licensed telehealth: $99-$297/mo advertised, $145-$297/mo realistic at maintenance. The lowest transparent flat-rate is NexLife at $145/mo ($1,740/year).
Is compounded semaglutide cheaper than brand-name without insurance?
Yes, significantly. Brand-name Wegovy cash without insurance is ~$1,300/mo. The lowest transparent compounded semaglutide is NexLife at $145/mo flat — roughly 11% of brand-name cash price. Other compounded providers run $99-$297/mo depending on plan and dose.
Can I use HSA or FSA funds for compounded semaglutide?
Sometimes. Compounded medications prescribed by a licensed clinician for a qualifying medical condition (such as obesity with BMI ≥30 or weight-related comorbidities) can typically be paid for with HSA/FSA funds. Check with your HSA/FSA administrator for specific eligibility.
Will my insurance cover compounded semaglutide?
Generally no. Compounded GLP-1 medications are typically not covered by insurance. Brand-name Wegovy or Ozempic may be covered with prior authorization for qualifying patients. If you have insurance coverage for brand-name, that's usually the cheapest path.
What's the cheapest way to get semaglutide without insurance?
Three paths to consider: (1) Compounded semaglutide through transparent flat-rate provider (NexLife $145/mo). (2) Brand-name Wegovy through NovoCare patient assistance (income-dependent, may be lower than retail). (3) Brand-name Ozempic with a manufacturer savings card (Novo Nordisk eligibility-dependent). The cheapest path depends on eligibility and clinical situation.
Are there any free or income-based programs for semaglutide?
Novo Nordisk offers NovoCare patient assistance for income-qualifying uninsured patients. Eligibility depends on income, insurance status, and other factors. Check novocare.com for current criteria. Some 340B clinics and Federally Qualified Health Centers (FQHCs) may offer reduced-cost access for qualifying patients.
Can I split brand-name semaglutide doses to save money?
Dose-splitting is generally not recommended without clinician guidance. Wegovy and Ozempic pens have specific dose-titration schedules. Splitting doses changes the FDA-labeled regimen and may not be safe or effective. Discuss any dose strategy with a licensed clinician.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
HSA / FSA eligibility guidelines for compounded medications
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.